FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308208497> ?p ?o ?g. }

• W4308208497 endingPage "e058034" @default.
• W4308208497 startingPage "e058034" @default.
• W4308208497 abstract "Objective To examine the comparative efficacy and complications of long-acting and intermediate-acting insulin for different patient characteristics for type 1 diabetes mellitus (T1DM). Design Systematic review and individual patient data (IPD) network meta-analysis (NMA). Data sources MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were searched through June 2015. Eligibility criteria Randomised controlled trials (RCTs) on adults with T1DM assessing glycosylated haemoglobin (A1c) and severe hypoglycaemia in long-acting and intermediate-acting insulin regimens. Data extraction and synthesis We requested IPD from authors and funders. When IPD were not available, we used aggregate data. We conducted a random-effects model, and specifically a one-stage IPD-NMA for those studies providing IPD and a two-stage IPD-NMA to incorporate those studies not providing IPD. Results We included 28 RCTs plus one companion report, after screening 6680 titles/abstracts and 205 full-text articles. Of the 28 RCTs, 27 studies provided data for the NMA with 7394 participants, of which 12 RCTs had IPD on 4943 participants. The IPD-NMA for A1c suggested that glargine once daily (mean difference [MD]=−0.31, 95% confidence interval [CI]: −0.48 to −0.14) and detemir once daily (MD=−0.25, 95% CI: –0.41 to −0.09) were superior to neutral protamine Hagedorn (NPH) once daily. NPH once/two times per day improved A1c compared with NPH once daily (MD=−0.30, 95% CI: –0.50 to −0.11). Results regarding complications in severe hypoglycaemia should be considered with great caution due to inconsistency in the evidence network. Accounting for missing data, there was no evidence of inconsistency and long-acting insulin regimens ranked higher regarding reducing severe hypoglycaemia compared with intermediate-acting insulin regimens (two-stage NMA: glargine two times per day SUCRA (Surface Under the Cumulative Ranking curve)=89%, detemir once daily SUCRA=77%; one-stage NMA: detemir once daily/two times per day SUCRA=85%). Using multiple imputations and IPD only, complications in severe hypoglycaemia increased with diabetes-related comorbidities (regression coefficient: 1.03, 95% CI: 1.02 to 1.03). Conclusions Long-acting insulin regimens reduced A1c compared with intermediate-acting insulin regimens and were associated with lower severe hypoglycaemia. Of the observed differences, only glargine once daily achieved a clinically significant reduction of 0.30%. Results should be interpreted with caution due to very low quality of evidence. PROSPERO registration number CRD42015023511." @default.
• W4308208497 created "2022-11-09" @default.
• W4308208497 creator A5007761401 @default.
• W4308208497 creator A5015669760 @default.
• W4308208497 creator A5031454086 @default.
• W4308208497 creator A5035891540 @default.
• W4308208497 creator A5046267575 @default.
• W4308208497 creator A5060060602 @default.
• W4308208497 creator A5078044277 @default.
• W4308208497 creator A5082525215 @default.
• W4308208497 creator A5082927689 @default.
• W4308208497 creator A5091235150 @default.
• W4308208497 date "2022-11-01" @default.
• W4308208497 modified "2023-10-06" @default.
• W4308208497 title "Comparative efficacy and complications of long-acting and intermediate-acting insulin regimens for adults with type 1 diabetes: an individual patient data network meta-analysis" @default.
• W4308208497 cites W1617328014 @default.
• W4308208497 cites W179067283 @default.
• W4308208497 cites W1969298821 @default.
• W4308208497 cites W1973914781 @default.
• W4308208497 cites W1974840485 @default.
• W4308208497 cites W2004474087 @default.
• W4308208497 cites W2010699829 @default.
• W4308208497 cites W2018012924 @default.
• W4308208497 cites W2025269315 @default.
• W4308208497 cites W2026890622 @default.
• W4308208497 cites W2037593179 @default.
• W4308208497 cites W2040557955 @default.
• W4308208497 cites W2048798569 @default.
• W4308208497 cites W2050118439 @default.
• W4308208497 cites W2054412998 @default.
• W4308208497 cites W2075046475 @default.
• W4308208497 cites W2079816845 @default.
• W4308208497 cites W2085803274 @default.
• W4308208497 cites W2091808438 @default.
• W4308208497 cites W2098923148 @default.
• W4308208497 cites W2100950755 @default.
• W4308208497 cites W2102684459 @default.
• W4308208497 cites W2107039245 @default.
• W4308208497 cites W2107328434 @default.
• W4308208497 cites W2109051507 @default.
• W4308208497 cites W2111938541 @default.
• W4308208497 cites W2111999709 @default.
• W4308208497 cites W2113144077 @default.
• W4308208497 cites W2114796329 @default.
• W4308208497 cites W2129821518 @default.
• W4308208497 cites W2131701504 @default.
• W4308208497 cites W2137670391 @default.
• W4308208497 cites W2140521029 @default.
• W4308208497 cites W2140699272 @default.
• W4308208497 cites W2141452626 @default.
• W4308208497 cites W2155772830 @default.
• W4308208497 cites W2157105694 @default.
• W4308208497 cites W2167672314 @default.
• W4308208497 cites W2172193326 @default.
• W4308208497 cites W2227168049 @default.
• W4308208497 cites W2289189593 @default.
• W4308208497 cites W2298788870 @default.
• W4308208497 cites W2444667591 @default.
• W4308208497 cites W2567362164 @default.
• W4308208497 cites W2586645431 @default.
• W4308208497 cites W2588681363 @default.
• W4308208497 cites W2604378711 @default.
• W4308208497 cites W2800879685 @default.
• W4308208497 cites W2947641233 @default.
• W4308208497 cites W2975424845 @default.
• W4308208497 cites W2978795816 @default.
• W4308208497 cites W3012706688 @default.
• W4308208497 cites W3015163167 @default.
• W4308208497 cites W3036199105 @default.
• W4308208497 cites W3138717815 @default.
• W4308208497 cites W3198969512 @default.
• W4308208497 cites W4211138256 @default.
• W4308208497 cites W4212810717 @default.
• W4308208497 cites W4233080080 @default.
• W4308208497 doi "https://doi.org/10.1136/bmjopen-2021-058034" @default.
• W4308208497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36332950" @default.
• W4308208497 hasPublicationYear "2022" @default.
• W4308208497 type Work @default.
• W4308208497 citedByCount "4" @default.
• W4308208497 countsByYear W43082084972022 @default.
• W4308208497 countsByYear W43082084972023 @default.
• W4308208497 crossrefType "journal-article" @default.
• W4308208497 hasAuthorship W4308208497A5007761401 @default.
• W4308208497 hasAuthorship W4308208497A5015669760 @default.
• W4308208497 hasAuthorship W4308208497A5031454086 @default.
• W4308208497 hasAuthorship W4308208497A5035891540 @default.
• W4308208497 hasAuthorship W4308208497A5046267575 @default.
• W4308208497 hasAuthorship W4308208497A5060060602 @default.
• W4308208497 hasAuthorship W4308208497A5078044277 @default.
• W4308208497 hasAuthorship W4308208497A5082525215 @default.
• W4308208497 hasAuthorship W4308208497A5082927689 @default.
• W4308208497 hasAuthorship W4308208497A5091235150 @default.
• W4308208497 hasBestOaLocation W43082084971 @default.
• W4308208497 hasConcept C126322002 @default.
• W4308208497 hasConcept C134018914 @default.
• W4308208497 hasConcept C168563851 @default.
• W4308208497 hasConcept C17744445 @default.
• W4308208497 hasConcept C187212893 @default.

• next